Second Primary Squamous Cell Carcinoma of the Head and Neck
2 clinical trials · Condition
◉ Watch Second Primary Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC (NCT05726370) | Dana-Farber Cancer Institute | 2023-05-20 |
| Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer (NCT04220775) | M.D. Anderson Cancer Center | 2020-03-18 |
Track Second Primary Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.